U.S. flag

An official website of the United States government

NM_194248.3(OTOF):c.5098G>C (p.Glu1700Gln) AND Nonsyndromic genetic hearing loss

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 28, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002228134.3

Allele description [Variation Report for NM_194248.3(OTOF):c.5098G>C (p.Glu1700Gln)]

NM_194248.3(OTOF):c.5098G>C (p.Glu1700Gln)

Genes:
LOC112840921:BRD4-independent group 4 enhancer GRCh37_chr2:26685720-26686919 [Gene]
OTOF:otoferlin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p23.3
Genomic location:
Preferred name:
NM_194248.3(OTOF):c.5098G>C (p.Glu1700Gln)
Other names:
DFNB9: otoferlin; NM_194248.2(OTOF):c.5098G>C
HGVS:
  • NC_000002.12:g.26463969C>G
  • NG_009937.1:g.99730G>C
  • NG_060956.1:g.449C>G
  • NM_001287489.2:c.5098G>C
  • NM_004802.4:c.2797G>C
  • NM_194248.3:c.5098G>CMANE SELECT
  • NM_194322.3:c.3028G>C
  • NM_194323.3:c.2797G>C
  • NP_001274418.1:p.Glu1700Gln
  • NP_004793.2:p.Glu933Gln
  • NP_919224.1:p.Glu1700Gln
  • NP_919303.1:p.Glu1010Gln
  • NP_919304.1:p.Glu933Gln
  • NC_000002.11:g.26686837C>G
  • NM_194248.1:c.5098G>C
  • NM_194248.2:c.5098G>C
  • NM_194248.3:c.5098G>C
  • c.5098G>C
Protein change:
E1010Q
Links:
dbSNP: rs199766465
NCBI 1000 Genomes Browser:
rs199766465
Molecular consequence:
  • NM_001287489.2:c.5098G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004802.4:c.2797G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_194248.3:c.5098G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_194322.3:c.3028G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_194323.3:c.2797G>C - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
variation affecting protein [Variation Ontology: 0002]

Condition(s)

Name:
Nonsyndromic genetic hearing loss
Synonyms:
Nonsyndromic hearing loss and deafness; Non-syndromic genetic deafness; Nonsyndromic genetic deafness
Identifiers:
MONDO: MONDO:0019497; MedGen: C5680182; Orphanet: 87884

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002512134ClinGen Hearing Loss Variant Curation Expert Panel
reviewed by expert panel

(clingen hl acmg specifications otof myo15a v1)
Pathogenic
(Jun 28, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Hearing Loss Variant Curation Expert Panel, SCV002512134.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.5098G>C (p.Glu1700Gln) variant in OTOF is a missense variant predicted to cause a substitution of glutamic acid by glutamine at amino acid 1700. The filtering allele frequency (the lower threshold of the 95% CI of 152/44874) of the c.5098G>C (p.Glu1700Gln) is 0.2948% for East Asian chromosomes by gnomAD v4.1.0, which meets the ClinGen Hearing Loss VCEP threshold (≥0.003) for BS1. However, based on the evidence outlined below, the ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for nonsyndromic hearing loss outweighs its high allele frequency the East Asian population, given it is reported as a founder mutation in the Taiwanese population (PMID: 20224275). Therefore, the BS1 code will not contribute to the overall classification. The computational predictor REVEL gives a score of 0.85 which is above the threshold of ≥ 0.7 (PP3). This variant has been detected in at least 18 individuals with autosomal recessive nonsyndromic hearing loss. Eight individuals were homozygous for the variant (PMIDs: 20224275, 35106950). Six individuals were compound heterozygous for the variant and a pathogenic or likely pathogenic variant with phase unknown (p.Glu841Lys, c.4961-1G>A, p.Arg1344*, p.Arg500*; PMID: 28766844). Four individuals were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and confirmed in trans by parental testing (p.Pro1628Thr; PMID: 34692690) (PM3_VeryStrong). At least one patient with this variant displayed features of auditory neuropathy spectrum disorder, which is highly specific for OTOF (PP4; PMID: 28766844). The variant has been reported to segregate with hearing loss in multiple affected family members from two families (PP1_Strong; PMIDs: 20224275, 34692690). In summary, this variant meets the criteria to be classified as pathogenic for nonsyndromic genetic hearing loss, based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP (PP3, PM3_VeryStrong, PP4, PP1_Strong; Version 2; 5/15/24).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024